𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Population prevalence and incidence of Parkinson’s disease in an Australian community

✍ Scribed by P. Mehta; A. Kifley; J. J. Wang; E. Rochtchina; P. Mitchell; C. M. Sue


Book ID
109003086
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
59 KB
Volume
37
Category
Article
ISSN
1444-0903

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Incidence of Parkinson's disease and aty
✍ Yaroslav Winter; Yury Bezdolnyy; Elena Katunina; Gagik Avakjan; Jens P. Reese; J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 1 views

## Abstract Data on the incidence of Parkinson's disease (PD) and atypical parkinsonian syndromes (APS) in East European countries and Asia are limited. The objective of this prospective population‐based study was to determine the incidence of PD and APS in the Russian population. The study area wa

Incidence of Parkinson's disease and par
✍ Jan Linder; Hans Stenlund; Lars Forsgren 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

## Abstract The differential diagnosis of parkinsonian disorders is difficult, especially early in the course of the diseases. The clinical subtypes of Parkinson's disease (PD) have not so far been described in newly diagnosed patients. We present a prospective incidence cohort study of patients wi

The incidence of dementia in an Australi
✍ Louise M. Waite; G. Anthony Broe; David A. Grayson; Helen Creasey 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

## Abstract ## Objectives Limited Australian dementia incidence data are available. This study aimed to identify the incidence of dementia and its subtypes in an Australian community dwelling population. ## Method A community dwelling sample of 647 subjects aged ≥75 years at recruitment were fol

Prevalence and clinical features of comm
✍ Yue Huang; Glenda M. Halliday; Himesha Vandebona; George D. Mellick; Frank Masta 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 1 views

## Abstract We determined the prevalence of two common leucine‐rich repeat kinase 2 (LRRK2) gene mutations in Australian patients with Parkinson's disease (PD). Of 830 affected patients, eight were heterozygous for the G2019S mutation, and two were heterozygous for the R1441H (4,322 G > A) mutation